Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Nurix Therapeutics, Inc. NRIX

Healthcare  —  Biotechnology
23.08 (0.57) (2.41%) as of 25 Sep
Market cap
$2.5B
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

May '26 Feb '26 Nov '25 Aug '25 Older periods
Cash and Short Term Investments 443.53 540.73 592.94 428.83

+8 more quarters
Total current assets 456.48 554.39 606.82 440.60
Property, Plant, Equpment (Net) 20.01 21.70 22.49 20.50
Long-term assets (Other) 8.95 8.38 8.31 8.34
Total non-current assets 79.06 81.74 81.32 81.87
Total Assets 535.54 636.13 688.14 522.47
Accounts Payable 12.21 10.29 11.22 8.61
Accrued Expenses 43.27 59.95 54.85 43.96
Current Revenue (Deferred) 13.32 18.75 17.58 25.99
Total current liabilities 72.02 92.20 86.47 82.35
Non-current Revenue (Deferred) 5.97 7.59 10.01 15.18
Total non-current liabilities 60.89 63.04 62.92 67.87
Total liabilities 132.91 155.24 149.39 150.22
Additional Paid In Capital 1,582.60 1,571.13 1,541.77 1,297.06
Common Stock (Net) 0.10 0.10 0.10 0.08
Retained Earnings (1,179.93) (1,090.40) (1,003.23) (925.00)
Common Equity (Total) 402.63 480.89 538.75 372.25
Shareholders Equity (Total) 402.63 480.89 538.75 372.25
Shareholders Equity and Liabilities (Total) 535.54 636.13 688.14 522.47
Shares (Common) 103.70 103.40 101.81 76.87
Shareholders Equity (Tangible) 402.63 480.89 538.75 372.25
Net Debt (443.53) (540.73) (592.94) (428.83)

Fold the line items

In millions of $ except per-share values · columns are period end dates